+
Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

What are your goals for visiting NephU?(Required)
How would you like to hear from us?(Required)
Agree(Required)
This field is for validation purposes and should be left unchanged.

Archives

Loading Events

IgA Nephropathy – From Pathogenesis to Current Management

IgA Nephropathy – From Pathogenesis to Current Management

This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. During this presentation you will learn the clinical presentation, diagnosis, prognosis, and unmet treatment needs of IgAN. You will then take a deep dive into the current understanding of IgAN pathogenesis including the four hit cascade and the key role B-cells and APRIL (A PRoliferation-Inducing Ligand) play in driving disease progression.

Location

The Bowman

9306 Harford Road
Parkville, MD 21234 United States
+ Google Map
410-665-8600 View Venue Website

Featuring

Alf Carroll

Alf Carroll, DMSc, PA-C

Nephrology Senior Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Alf Carroll, DMSc, PA-C is a Senior Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization. He earned his Bachelor of Science in Biology and Master of Science in Physician Assistant Studies from Northeastern University in Boston, Massachusetts. He worked clinically as a Physician Assistant in the Emergency Department at Massachusetts General Hospital and South Shore Hospital in the Boston area. Prior to joining Otsuka, Alf held a position at AstraZeneca Pharmaceuticals on their Market Access team focusing on large health systems in New England, covering the cardiovascular, renal, endocrine, and respiratory therapeutic areas.

Kimberly Means

Kimberly Means, PharmD, BCCCP, BSN, RN

Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Kimberly Means, PharmD, BCCCP, BSN, RN, is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).  Dr Means earned her B.S. in Nursing (BSN) and her Doctor of Pharmacy (PharmD) from Virginia Commonwealth University (VCU) in Richmond, Virginia.  She completed a PGY-1 Pharmacy Practice Residency and a PGY-2 Critical Care Residency at VCU Health in Richmond, Virginia.  Prior to joining Otsuka, she worked as a critical care nurse at VCU Health, a Critical Care Clinical Pharmacist at Henrico Doctors’ Hospital, and a Clinical Pharmacist in Surgical Services at VCU Health.  During her time as a Clinical Assistant Professor at the VCU School of Pharmacy and VCU Health she served as a preceptor for pharmacy students and pharmacy residents.  Dr Means is a Board Certified Critical Care Pharmacotherapy Specialist (BCCCP).

Alf Carroll, DMSc, PA-C and Kimberly Means, PharmD, BCCCP, BSN, RN are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.